Direct Source B2B Industrial Whitepaper

High-Quality Eucalyptus Oil For Asthma: Factory & Pricelist

Precision-fractionated botanical APIs, compliant with BP/EP/USP standards. Sourced directly from our 28,600 m² GMP extraction facility in Jiangxi for global pharmaceutical, nutraceutical, and clinical formulation buyers.

28,600 m²
GMP Production Campus (Jiangxi)
≥ 85.0%
Pharmaceutical 1,8-Cineole Assay
12 Lines
Automated Continuous Distillation
100%
GC-MS/HPLC Monitored Traceability

Therapeutic Efficacy of Eucalyptus Oil in Asthma Formulations

Standardizing 1,8-cineole (eucalyptol) chemistry for mucociliary clearance, inflammation suppression, and bronchial spasm relief.

1,8-Cineole Molecular Pathway

Eucalyptol acts as a potent inhibitor of arachidonic acid metabolism, blocking downstream tumor necrosis factor-alpha (TNF-α) and leukotriene B4 (LTB4) synthesis. This molecular mechanism leads to rapid reduction in airway hyperresponsiveness and smooth muscle constriction.

Secretolytic & Mucociliary Action

In acute or chronic bronchial inflammation, excess viscous mucus severely limits peak expiratory flow. Pharmacopoeial eucalyptus oil stimulates bronchial ciliary beat frequency (CBF), accelerating surfactant production and improving expectoration without stimulating systemic tachycardia.

Steroid-Sparing Co-Therapy

Clinical data validate that controlled inhalation or encapsulated oral administration of cineole fractions allows glucocorticoid dose reduction by up to 36% in patients with stable bronchial asthma, serving as a validated phyto-therapeutic co-treatment.

Why Tier-1 Formulators Partner with Our Jiangxi Factory

Combining local raw botanical harvesting economics with European cGMP compliant processing lines.

Botanical Proximity

Our extraction campus is located directly within Jiangxi's primary forestry zone, yielding sustainable wild and farm-harvested Eucalyptus globulus feedstock with zero transshipment degradation.

Continuous Rectification

Unlike atmospheric pot distillers, our 6 essential oil lines feature multi-stage vacuum fractional rectification to refine crude eucalyptus oil (60%) up to pharmaceutical-grade 80% to 85% eucalyptol purities.

Zero Contamination QA

Every industrial run is screened by Shimadzu GC-MS and Waters HPLC for residual heavy metals (<0.5 ppm), volatile solvents, and chlorinated terpenes, meeting strict pharmacopoeial limits.

Scalable Contract Filling

Direct pipeline supply into 25kg fluorinated HDPE carboys, 180kg epoxy-lined steel drums, or automated filling of amber dropper bottles for private-label brands across North America, Europe, and Asia.

Commercial Specifications & Tiered Pricelist Structure

Reference wholesale indices based on contract volume, packaging requirements, and pharmaceutical monograph compliance.

Grade Designation Assay (1,8-Cineole) Refractive Index (20°C) Compliance Standard MOQ Indicative Price (FOB Ningbo/Shanghai)
Technical/Aroma Grade 60.0% – 65.0% 1.458 – 1.465 ISO 3065 / Industrial 100 kg $12.50 – $15.00 / kg
Cosmetic/Diffuser Grade 70.0% – 75.0% 1.459 – 1.466 IFRA / REACH Registered 50 kg $16.80 – $19.50 / kg
Pharma-Standard (EP/BP) ≥ 80.0% 1.458 – 1.467 European Pharmacopoeia (EP 10.0) 25 kg $21.50 – $25.00 / kg
Ultra-Purified Clinical API ≥ 85.0% – 99.0% 1.457 – 1.462 USP / cGMP Monograph Verified 25 kg $28.00 – $34.50 / kg

*Official pricelists adjust based on quarterly feedstock yields, ocean freight, and custom distillation contracts. Inquire for current CIF spot pricing.

Regulatory Support for Regulated Global Markets

Overcoming regional compliance hurdles for respiratory therapeutic products through comprehensive documentation and quality guarantees.

European Union (EU-REACH & EMA)

For bronchial relief products and aromatherapy medical devices in the EU, Baicao provides complete REACH dossiers, IFRA 51st Amendment certificates, allergen screening sheets (confirming limonene levels <1.5%), and Traditional Herbal Medicinal Product (THMPD) compliant documentation.

US FDA DMF & OTC Monograph

Our essential oils are processed in FDA-registered cleanrooms. For manufacturers formulating OTC respiratory vaporizing ointments or inhalation inhalant capsules under 21 CFR Part 341, we assist with Active Substance Master File (ASMF) and Drug Master File (DMF) technical paperwork.

Complete Batch Dossiers

Every commercial consignment ships with lot-traceable documentation: Shimadzu GC-MS Chromatogram, Certificate of Analysis (COA), 16-Section GHS-compliant SDS, Non-GMO verification, Certificate of Origin, and BSE/TSE declaration forms for seamless customs clearance.

Industry Trends & Practical Formulation Pathways

The convergence of plant-derived medicines and modern pulmonary healthcare applications.

Rising Clean-Label Demand

Global pharmaceutical brands are moving away from petrochemical excipients. High-assay 1,8-cineole is increasingly replacing synthetic decongestants in chest rubs, vapor patches, and sauna therapy blends due to its proven mucolytic performance and consumer preference for botanical origins.

Advanced Microencapsulation

A growing application trend involves microencapsulating pure eucalyptus terpenes into enteric-coated softgels for lower respiratory tract delivery, minimizing gastric irritation while ensuring controlled release directly to systemic circulation.

Ultrasonic Ultrasonic Inhalation Solutions

Medical device companies partner with us to supply water-dispersible micro-emulsions of purified eucalyptol for specialized clinical nebulizers and home steam dispensers, offering rapid therapeutic dispersion during seasonal asthmatic peaks.

Frequently Asked Questions for Sourcing Managers

Key information on distillation processes, technical compliance, and international order fulfillment.

What specific eucalyptus species is used for asthma and respiratory oil production?
For medical, pharmaceutical, and respiratory formulations, Eucalyptus globulus (Blue Gum) is the required species due to its high native content of 1,8-cineole (eucalyptol). Unlike Eucalyptus citriodora (which is dominated by citronellal and used primarily for insect repellents) or Eucalyptus radiata, E. globulus yields the precise terpene profile required by the European Pharmacopoeia (EP) and United States Pharmacopeia (USP) for therapeutic lung and bronchial indications.
How does Baicao guarantee the exact concentration of 1,8-cineole across harvest seasons?
Crude steam-distilled eucalyptus oil contains volatile monoterpenes like alpha-pinene, beta-pinene, and phellandrene, with cineole concentrations hovering around 60%. To maintain batch-to-batch consistency despite climate swings, our Jiangxi plant passes the crude oil through fractional vacuum rectification columns. This secondary distillation accurately concentrates the 1,8-cineole fraction to guaranteed target assays (e.g., ≥70%, ≥80%, or ≥85%), removing undesired lighter terpenes and seasonal variations.
Can inhalation of eucalyptus oil trigger asthma attacks in sensitive individuals?
Yes. In clinical literature, undiluted crude eucalyptus vapor or direct application around nasal passages can stimulate cold-sensitive TRPM8 receptors and trigger bronchospasms in young children or hyper-reactive asthmatic patients. Because of this, institutional buyers must formulate eucalyptus oil within balanced therapeutic dilution limits (typically 0.5% – 2.0% in steam diffusers, chest rubs, or microencapsulated oral forms). As a primary ingredients factory, we provide detailed technical dosage frameworks, IFRA safety certificates, and toxicity thresholds to assist product developers in building safe commercial treatments.
What are the lead times and container loading capacities for bulk international orders?
Standard barrel packaging consists of 180kg net weight fluorinated/epoxy-lined steel drums (4 drums per pallet, 80 drums/14.4 metric tons per 20ft container) or 25kg UN-rated drums for smaller runs. Standard factory lead time for up to 5 metric tons is 7 to 10 working days from PO confirmation. Sea shipping routes via Ningbo, Shanghai, or Shenzhen port offer prompt weekly sailings to Europe, North America, Southeast Asia, and Latin America, accompanied by dangerous goods (DG) packing declarations and marine transport certificates.
Does your factory support private label OEM manufacturing for ready-to-retail products?
Yes. Jiangxi Baicao Pharmaceutical provides full turnkey OEM/ODM services. We manage automatic bottling in 10ml, 15ml, 30ml, 50ml, or 100ml amber dropper glass bottles with child-resistant/tamper-evident caps, customized primary labeling, UV-coated outer gift boxes, and complete packaging assembly. Formulation blending with carrier oils (sweet almond, jojoba) or synergistic respiratory essential oils (peppermint, tea tree, thyme) is executed under cleanroom GMP operating conditions.
Quick RFQ Sample Request